Trial intelligence / Profile preview

Patient-controlled propofol sedation with alfentanil vs remifentanil in ERCP

2009-012398-36Phase 4Completed

Sponsor
Helsinki University Hospital
Start
May 2009
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in biliary disease and pancreatic diseases comparing Propofol + alfentanil with Propofol + remifentanil (2 arms). Primary endpoints: Pulse, Blood pressure and 6 more. Started May 2009; status: completed.

02

Drugs

remifentanilalfentanilpropofol
03

Conditions

biliary diseasepancreatic diseases

Beyond the preview

Go deeper on 2009-012398-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012398-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call